Intermediate Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Postpartum Women with a History of Venous Thromboembolism (Highlow Study) Intermediate Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Postpartum Women with a History of Venous Thromboembolism (Highlow Study)

Intermediate Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Postpartum Women with a History of Venous Thromboembolism (Highlow Study)

July 13, 2022 | Saskia Middeldorp, M.D., Ph.D., Radboud University Medical Center, Nijmegen, the Netherlands

Read more
The VarioPath Project: Determining Effect Sizes of Pathogenic Variants in Platelet Disorder Genes Using Clinical Data from 0.5M Whole Exome–Sequenced U.K. Biobank Participants The VarioPath Project: Determining Effect Sizes of Pathogenic Variants in Platelet Disorder Genes Using Clinical Data from 0.5M Whole Exome–Sequenced U.K. Biobank Participants

The VarioPath Project: Determining Effect Sizes of Pathogenic Variants in Platelet Disorder Genes Using Clinical Data from 0.5M Whole Exome–Sequenced U.K. Biobank Participants

July 12, 2022 | Janine Collins, M.B. B.Chir., University of Cambridge, Cambridge, U.K.
Read more
RSS
12345